NIAID is developing multiple vaccine candidates to prevent Zika virus infection. These include:Early-stage trials examine whether an experimental vaccine is safe and generates immune responses in vaccinated volunteers. A safe and effective, fully licensed Zika vaccine will likely not be available for several years.